News
Recommendations Provided for Treatment of Ulcerative Colitis
Infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, ustekinumab recommended over no tx
Your search for tofacitinib returned 30 results
ACR 2019, News
Few Serious Infections in Offspring Exposed to Non-TNFi Biologics, Tofacitinib
Researchers compared the risk for serious infections in offspring of mothers with chronic inflammatory diseases who received non-TNFi biologics or tofacitinib during pregnancy vs offspring who were unexposed, but exposed to TNFi in utero.
News
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA
TNFi recommended over secukinumab, ixekizumab for AS and nonradiographic axial SpA as first biologic
News
Herpes Zoster Risk and Vaccination Recommendations in Patients With Psoriasis, Psoriatic Arthritis
Investigators assessed the risk for herpes zoster and provided recommendations regarding treatment in patients with psoriasis.
Musculoskeletal Disorders
Tofacitinib Benefits Sustained for Two Years in Patients With RA
The clinical benefits of tofacitinib in combination with methotrexate are sustained over 2 years among patients with rheumatoid arthritis (RA), according to a study published online January 22 in Arthritis & Rheumatology.
ACR/ARHP 2018 Annual Meeting
CVD Risk Reduced in Rheumatoid Arthritis Treated With Methotrexate and bDMARDs
A reduction in risk for cardiovascular disease has been reported among patients with rheumatoid arthritis who are receiving concomitant therapy with methotrexate and biologic disease-modifying antirheumatic drugs.
ACR/ARHP 2018 Annual Meeting
Venus Thromboembolism Risk Assessed With Tofacitinib, TNF Inhibitors
Although the incidence rate of venous thromboembolism was numerically higher in patients treated with tofacitinib vs TNF inhibitors, the risk was not statistically significant.
ACR/ARHP 2018 Annual Meeting
Abatacept May Reduce Diabetes Risk in Rheumatoid Arthritis
The researchers concluded their findings indicate that for patients with RA, abatacept reduced the risk for diabetes and "potentially improved insulin sensitivity and glycemic profile."
ACR/ARHP 2018 Annual Meeting
RA Remission Compared for Tofacitinib Alone vs. Steroid Plus Tofacitinib Tx
The results support combination therapy with intra-articular steroid injections and tofacitinib to achieve clinical and radiographic remission in patients with early rapid radiographic progression RA.
ACR/ARHP 2018 Annual Meeting
Clinical Efficacy of Tofacitinib Once-Daily vs Twice-Daily Examined in RA
Tofacitinib extended release has comparable clinical efficacy to tofacitinib administered twice daily.
